September 18, 2019

Eric K. Steffe

Mr. Steffe is a director in the Biotechnology/Chemical Group where he counsels domestic and foreign clients in various matters involving biotechnology patent law. Mr. Steffe leads teams who create and manage complicated patent portfolios protecting pipeline and FDA-approved products for companies in the areas of immunology, antisense, protein therapy, personalized medicine and diagnostics, therapeutic antibodies, small molecules and vaccines. His also has significant expertise representing clients involved in contested case proceedings before the USPTO, including ex parte and inter partes patent reexaminations and interferences. 

Articles in the National Law Review database by Eric K. Steffe

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Wednesday, September 18, 2019
Tuesday, September 24, 2019
Thursday, September 26, 2019
Thursday, October 17, 2019
Wednesday, October 23, 2019
Wednesday, November 6, 2019
Wednesday, November 13, 2019
Wednesday, December 11, 2019